Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Entecavir Switch vs Lamivudine Continuation in Chronic Hepatitis B
NCT00625339Phase 4Completed
- Sponsor
- Yonsei University
- Start
- Feb 2008
- Primary completion
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of entecavir in Chronic Hepatitis B (CHB), sponsored by Yonsei University. Started Feb 2008; status: completed.
02
Drugs
entecavir
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT00625339.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00625339.